as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.13%
Downside
1.87%
Upside
52 Week's Low
52 Week's High
24.72%
Downside
22.04%
Upside
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$30.0B
EPS (TTM)
2.0503
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.27%
PE Ratio (TTM)
53.16
Industry PE ratio
16.65525641025641
P/B Ratio
53.1597
PEG Ratio
0.9631
EBITDA
923.3M
Revenue (TTM)
4.3B
Profit Margin
13.29%
Return On Equity TTM
22.83%
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (44.87x)
December 31, 2024
Industry (16.66x)
September 17, 2025
Today (53.16x)
September 17, 2025
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 53.16x
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $30.0B | -21.72% | 53.16 | 13.29% | |
BUY | $146.7B | 149.51% | 58.92 | 13.55% | |
BUY | $144.0B | 78.01% | 50.02 | 12.25% | |
BUY | $231.1B | 24.47% | 16.66 | 32.43% | |
BUY | $120.8B | -12.63% | 26.02 | 13.63% |
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹1,15,434
Returns
₹15,434
(+15.43%)
Returns from Dexcom, Inc. Stock
₹10,836 (+10.84%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $102.08
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
25.15%UPSIDE
Target Price
$102.08
Current Price
$76.41
Analyzed by
30 Analysts
Target
$102.08
Dexcom, Inc. target price $102.08, a slight upside of 25.15% compared to current price of $76.41. According to 30 analysts rating.
Investment in Dexcom, Inc. Shares on INDmoney has grown by 114.89% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:114.89%Â versus previous 30 day period
Search interest for Dexcom, Inc. Stock has increased by 174% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:174%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 September
Tue, 04:10 PM
-Dexcom CEO Kevin R. Sayer takes medical leave; interim roles announced for President and COO Jacob S. Leach.
Tue, 09:12 PM
-Wall Street remains bullish on DexCom after strong Q2 results, with multiple analysts reiterating Buy ratings and price targets.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Dexcom, Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $1.03 billion to $1.15 billion, marking an average growth of 10.5% each quarter.
Profit Spike
Dexcom, Inc. has shown strong profit growth over the last two quarters. The company's net profit increased from $105.4 million to $179.8 million, representing an average quarterly growth of 41.4%. This positive trend indicates that the company's profitability has been consistently improving.
Against Peers
In the last 3 years, Boston Scientific Corp. has given 137.4% return, outperforming this stock by 152.4%
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.9% return, outperforming this stock by 9.7%
Price Dip
In the last 1 month, DXCM stock has moved down by -5.3%
Organisation | Dexcom, Inc. |
Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Mr. Kevin Ronald Sayer |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Ms. Leverne Marsh | Executive Vice President of Marketing |
Mr. Kevin Ronald Sayer | Executive Chairman & CEO |
Mr. Jacob Steven Leach | President & COO |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs |
Dexcom, Inc. share price today is $76.41 as on at the close of the market. Dexcom, Inc. share today touched a day high of $77.84 and a low of $75.55.
Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $57.52 on . Dexcom, Inc. stock price today i.e. is closed at $76.41,which is 18.06% down from its 52 week high and 32.84% up from its 52 week low.
Dexcom, Inc. market capitalisation is $0.03T as on .
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $76.41 as on September 18, 2025 at 1:29 am IST, you will get 0.1309 shares of Dexcom, Inc.. Learn more about
fractional shares .
Dexcom, Inc. stock has given -21.72% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?